Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ifosfamide in pediatric oncology.

J de Kraker1

  • 1Emma Kinderziekenhuis/Children's Academic Medical Center, Department of Pediatric Oncology, Amsterdam, The Netherlands.

Anti-Cancer Drugs
|August 1, 1991
PubMed
Summary

Pediatric cancer research faces challenges in conducting single-drug studies due to small patient numbers. More data is needed on ifosfamide

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustainability assessment as problem structuring: three typical ways.

Sustainability science·2018
Same author

Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).

European journal of cancer (Oxford, England : 1990)·2015
Same author

Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study.

British journal of cancer·2014
Same author

Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.

European journal of cancer (Oxford, England : 1990)·2013
Same author

Incidence and outcomes of patients with late recurrence of Wilms' tumor.

Pediatric blood & cancer·2013
Same author

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

British journal of cancer·2008

Area of Science:

  • Pediatric Oncology
  • Clinical Pharmacology

Background:

  • Limited patient populations in pediatric oncology centers hinder single-drug Phase II studies.
  • Ifosfamide has been used in pediatric oncology for over a decade, yet comprehensive data remains scarce.

Purpose of the Study:

  • To highlight the importance of determining the role of ifosfamide in treating childhood cancers.
  • To address the knowledge gap regarding ifosfamide's efficacy and safety in pediatric patients.

Main Methods:

  • This abstract does not specify methods.
  • Further research is needed to establish ifosfamide's role.

Main Results:

  • This abstract does not specify results.
  • The current lack of data on ifosfamide in pediatric oncology is noted.

Conclusions:

  • Further investigation into ifosfamide is crucial for optimizing childhood cancer treatment.
  • Understanding ifosfamide's role is essential given chemotherapy's significance in pediatric oncology.

Related Experiment Videos